Literature DB >> 7945196

Structure of the human cyclo-oxygenase-2 gene.

S B Appleby1, A Ristimäki, K Neilson, K Narko, T Hla.   

Abstract

Cyclo-oxygenase (Cox), a rate-limiting enzyme in the synthesis of prostanoids, is encoded by two genes, Cox-1 and Cox-2, which are differentially expressed and regulated. Human Cox-1 and -2 polypeptides share 61% primary sequence identity. While the expression of Cox-1 is maximal in quiescent cells. Cox-2 expression is induced by growth factors and cytokines. We have screened a human genomic library with a probe from the 5'-untranslated region (UTR) of the human Cox-2 (hCox-2) cDNA and isolated two overlapping genomic clones. We have determined the DNA sequence of 0.8 kb upstream of the transcription start site, 6 kb of protein coding region, which includes 10 exons and 9 introns, as well as 2.5 kb of the 3'-UTR. The structures of the hCox-1 and hCox-2 and the murine TIS10 (Cox-2) genes are highly conserved, with a few exceptions. The 3'-UTRs of the Cox-1 and -2 genes are distinct; for example, the largest exon in the Cox-2 gene encodes the entire 3'-UTR, containing 22 copies of the 'AUUUA' RNA instability element. Sequence analysis of the 5'-flanking region has shown several potential transcription regulatory sequences, including a TATA box, a C/EBP motif, two AP-2 sites, three SP1 sites, two NF-kappa B sites, a CRE motif and an Ets-1 site. These efforts serve as a basis for future studies on transcriptional and post-transcriptional mechanisms of Cox-2 gene regulation.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7945196      PMCID: PMC1137291          DOI: 10.1042/bj3020723

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  18 in total

Review 1.  Cyclooxygenase gene expression in inflammation and angiogenesis.

Authors:  T Hla; A Ristimäki; S Appleby; J G Barriocanal
Journal:  Ann N Y Acad Sci       Date:  1993-11-30       Impact factor: 5.691

2.  The X-ray crystal structure of the membrane protein prostaglandin H2 synthase-1.

Authors:  D Picot; P J Loll; R M Garavito
Journal:  Nature       Date:  1994-01-20       Impact factor: 49.962

3.  TIS10, a phorbol ester tumor promoter-inducible mRNA from Swiss 3T3 cells, encodes a novel prostaglandin synthase/cyclooxygenase homologue.

Authors:  D A Kujubu; B S Fletcher; B C Varnum; R W Lim; H R Herschman
Journal:  J Biol Chem       Date:  1991-07-15       Impact factor: 5.157

4.  Prostaglandin endoperoxide synthase. The aspirin acetylation region.

Authors:  T Shimokawa; W L Smith
Journal:  J Biol Chem       Date:  1992-06-15       Impact factor: 5.157

5.  Structure of the mitogen-inducible TIS10 gene and demonstration that the TIS10-encoded protein is a functional prostaglandin G/H synthase.

Authors:  B S Fletcher; D A Kujubu; D M Perrin; H R Herschman
Journal:  J Biol Chem       Date:  1992-03-05       Impact factor: 5.157

6.  Induction of cyclooxygenase-2 by interleukin-1 alpha. Evidence for post-transcriptional regulation.

Authors:  A Ristimäki; S Garfinkel; J Wessendorf; T Maciag; T Hla
Journal:  J Biol Chem       Date:  1994-04-22       Impact factor: 5.157

7.  Human cyclooxygenase-2 cDNA.

Authors:  T Hla; K Neilson
Journal:  Proc Natl Acad Sci U S A       Date:  1992-08-15       Impact factor: 11.205

8.  Essential histidines of prostaglandin endoperoxide synthase. His-309 is involved in heme binding.

Authors:  T Shimokawa; W L Smith
Journal:  J Biol Chem       Date:  1991-04-05       Impact factor: 5.157

Review 9.  Prostanoid biosynthesis and mechanisms of action.

Authors:  W L Smith
Journal:  Am J Physiol       Date:  1992-08

10.  Cyclooxygenase-1 and -2 expression in rheumatoid synovial tissues. Effects of interleukin-1 beta, phorbol ester, and corticosteroids.

Authors:  L J Crofford; R L Wilder; A P Ristimäki; H Sano; E F Remmers; H R Epps; T Hla
Journal:  J Clin Invest       Date:  1994-03       Impact factor: 14.808

View more
  114 in total

Review 1.  One path to cell death in the nervous system.

Authors:  J Glasgow; R Perez-Polo
Journal:  Neurochem Res       Date:  2000-10       Impact factor: 3.996

2.  Calpain inhibitor I reduces the development of acute and chronic inflammation.

Authors:  S Cuzzocrea; M C McDonald; E Mazzon; D Siriwardena; I Serraino; L Dugo; D Britti; G Mazzullo; A P Caputi; C Thiemermann
Journal:  Am J Pathol       Date:  2000-12       Impact factor: 4.307

3.  NFκB and HIF display synergistic behaviour during hypoxic inflammation.

Authors:  Ulrike Bruning; Susan F Fitzpatrick; Till Frank; Marc Birtwistle; Cormac T Taylor; Alex Cheong
Journal:  Cell Mol Life Sci       Date:  2011-11-09       Impact factor: 9.261

4.  Interleukin-4 inhibits prostaglandin E2 production by freshly prepared adherent rheumatoid synovial cells via inhibition of biosynthesis and gene expression of cyclo-oxygenase II but not of cyclo-oxygenase I.

Authors:  E Sugiyama; H Taki; A Kuroda; T Mino; N Yamashita; M Kobayashi
Journal:  Ann Rheum Dis       Date:  1996-06       Impact factor: 19.103

Review 5.  Discovery of a new function of cyclooxygenase (COX)-2: COX-2 is a cardioprotective protein that alleviates ischemia/reperfusion injury and mediates the late phase of preconditioning.

Authors:  Roberto Bolli; Ken Shinmura; Xian-Liang Tang; Eitaro Kodani; Yu-Ting Xuan; Yiru Guo; Buddhadeb Dawn
Journal:  Cardiovasc Res       Date:  2002-08-15       Impact factor: 10.787

6.  Homeobox protein CDX2 reduces Cox-2 transcription by inactivating the DNA-binding capacity of nuclear factor-kappaB.

Authors:  Hiroyuki Mutoh; Hiroko Hayakawa; Hirotsugu Sakamoto; Kentaro Sugano
Journal:  J Gastroenterol       Date:  2007-09-25       Impact factor: 7.527

7.  Mechanism of cyclooxygenase-2 upregulation in late preconditioning.

Authors:  Yu-Ting Xuan; Yiru Guo; Yanqing Zhu; Hui Han; Robert Langenbach; Buddhadeb Dawn; Roberto Bolli
Journal:  J Mol Cell Cardiol       Date:  2003-05       Impact factor: 5.000

8.  Inhibition of inducible NO synthase, cyclooxygenase-2 and interleukin-1beta by torilin is mediated by mitogen-activated protein kinases in microglial BV2 cells.

Authors:  Y Choi; M K Lee; S Y Lim; S H Sung; Y C Kim
Journal:  Br J Pharmacol       Date:  2009-03       Impact factor: 8.739

9.  Effect of NS-398, a cyclooxygenase-2 selective inhibitor, on the cytotoxicity of cytotoxic T lymphocytes to ovarian carcinoma cells.

Authors:  Xinyan Wang; Yu Liang; Jun Wang; Min Wang
Journal:  Tumour Biol       Date:  2013-03-01

10.  Prostaglandin pathway gene therapy for sustained reduction of intraocular pressure.

Authors:  Román A Barraza; Jay W McLaren; Eric M Poeschla
Journal:  Mol Ther       Date:  2009-12-01       Impact factor: 11.454

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.